GLP-1 Agonists and Suicidal Ideation: The Evidence GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda) are widely prescribed for type 2 diabetes and obesity management
The clear winner: appetite control
GLP-1 medications can address several conditions, so patients may qualify for their use in various ways: Type 2 diabetes: Patients with an A1C of 6.5% or higher may be eligible for these medications to help regulate blood sugar
b) estudios donde el diagnstico de SOP fueron los criterios de Rotterdam, Institutos Nacionales de Salud (NIH) y/o Sociedad de Exceso de Andrgenos (AES)
Further epidemiological studies emphasize that as body mass index (BMI) increases, so does the incidence of developing asthma, specifically in those with atopic diseases, such as allergic rhinitis, allergic asthma, or atopic dermatitis [10, 13]